02042nam 2200373 a 450 991069717510332120230902161605.0(CKB)5470000002385159(OCoLC)794684490(EXLCZ)99547000000238515920120604d2009 ua 0engurmn|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry, FDA staff, and FDA-accredited third partiesManufacturer's notification of the intent to use accredited person under the accredited person inspection program authorized by Section 228 of the Food and Drug Administration Amendments Act of 2007 (FDAAA)[electronic resource][Rockville, Md.] :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health ;[Bethesda, Md.] :Center for Biologics Evaluation and Research,[2009]1 online resource (10 pages)Title from PDF title screen (viewed May 24, 2012)."Document issued on March 2, 2009.""This document supercedes the document which was issued on September 15, 2005."Guidance for industry, Food and Drug Administration staff, and Food and Drug Administration accredited third parties.Manufacturer's notification of the intent to use accredited person under the accredited person inspection program authorized by Section 228 of the Food and Drug Administration Amendments Act of 2007 (FDAAA)Medical instruments and apparatusGovernment policyUnited StatesMedical instruments and apparatusGovernment policyCenter for Devices and Radiological Health (U.S.)Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910697175103321Guidance for industry, FDA staff, and FDA-accredited third parties3467380UNINA